Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study

BACKGROUND: Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up campaign in Kilifi County for children aged younger than 5 years. Coverage with at least two PCV10 doses in children aged 2–11 mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammitt, Laura L, Etyang, Anthony O, Morpeth, Susan C, Ojal, John, Mutuku, Alex, Mturi, Neema, Moisi, Jennifer C, Adetifa, Ifedayo M, Karani, Angela, Akech, Donald O, Otiende, Mark, Bwanaali, Tahreni, Wafula, Jackline, Mataza, Christine, Mumbo, Edward, Tabu, Collins, Knoll, Maria Deloria, Bauni, Evasius, Marsh, Kevin, Williams, Thomas N, Kamau, Tatu, Sharif, Shahnaaz K, Levine, Orin S, Scott, J Anthony G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548991/
https://www.ncbi.nlm.nih.gov/pubmed/31000194
http://dx.doi.org/10.1016/S0140-6736(18)33005-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548991/
https://www.ncbi.nlm.nih.gov/pubmed/31000194
http://dx.doi.org/10.1016/S0140-6736(18)33005-8

Ejemplares similares